Annual Total Assets
$22.73 B
+$4.58 B+25.23%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual total assets is currently $22.73 billion, with the most recent change of +$4.58 billion (+25.23%) on 31 December 2023. During the last 3 years, it has risen by +$10.98 billion (+93.42%). VRTX annual total assets is now at all-time high.VRTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$22.24 B
+$2.11 B+10.47%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly total assets is currently $22.24 billion, with the most recent change of +$2.11 billion (+10.47%) on 30 September 2024. Over the past year, it has increased by +$514.00 million (+2.37%). VRTX quarterly total assets is now -7.01% below its all-time high of $23.92 billion, reached on 31 March 2024.VRTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.2% | +2.4% |
| 3 y3 years | +93.4% | +76.3% |
| 5 y5 years | +263.9% | +196.0% |
VRTX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +93.4% | -7.0% | +76.3% |
| 5 y | 5 years | at high | +263.9% | -7.0% | +196.0% |
| alltime | all time | at high | >+9999.0% | -7.0% | >+9999.0% |
Vertex Pharmaceuticals Incorporated Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.24 B(+10.5%) |
| June 2024 | - | $20.13 B(-15.8%) |
| Mar 2024 | - | $23.92 B(+5.2%) |
| Dec 2023 | $22.73 B(+25.2%) | $22.73 B(+4.6%) |
| Sept 2023 | - | $21.73 B(+6.8%) |
| June 2023 | - | $20.35 B(+7.2%) |
| Mar 2023 | - | $18.97 B(+4.5%) |
| Dec 2022 | $18.15 B(+35.1%) | $18.15 B(+8.6%) |
| Sept 2022 | - | $16.71 B(+7.2%) |
| June 2022 | - | $15.58 B(+9.3%) |
| Mar 2022 | - | $14.26 B(+6.1%) |
| Dec 2021 | $13.43 B(+14.3%) | $13.43 B(+6.4%) |
| Sept 2021 | - | $12.62 B(+3.2%) |
| June 2021 | - | $12.22 B(+0.9%) |
| Mar 2021 | - | $12.12 B(+3.1%) |
| Dec 2020 | $11.75 B(+41.3%) | $11.75 B(+4.0%) |
| Sept 2020 | - | $11.30 B(+10.6%) |
| June 2020 | - | $10.22 B(+14.9%) |
| Mar 2020 | - | $8.89 B(+6.9%) |
| Dec 2019 | $8.32 B(+33.2%) | $8.32 B(+10.7%) |
| Sept 2019 | - | $7.51 B(+6.8%) |
| June 2019 | - | $7.03 B(+7.5%) |
| Mar 2019 | - | $6.54 B(+4.8%) |
| Dec 2018 | $6.25 B(+76.1%) | $6.25 B(+35.2%) |
| Sept 2018 | - | $4.62 B(+6.6%) |
| June 2018 | - | $4.34 B(+9.7%) |
| Mar 2018 | - | $3.95 B(+11.5%) |
| Dec 2017 | $3.55 B(+22.4%) | $3.55 B(+10.9%) |
| Sept 2017 | - | $3.20 B(-2.7%) |
| June 2017 | - | $3.29 B(+11.5%) |
| Mar 2017 | - | $2.95 B(+1.7%) |
| Dec 2016 | $2.90 B(+15.9%) | $2.90 B(+11.0%) |
| Sept 2016 | - | $2.61 B(+2.4%) |
| June 2016 | - | $2.55 B(+2.5%) |
| Mar 2016 | - | $2.49 B(-0.4%) |
| Dec 2015 | $2.50 B(+7.0%) | $2.50 B(+2.7%) |
| Sept 2015 | - | $2.43 B(+2.5%) |
| June 2015 | - | $2.37 B(+9.6%) |
| Mar 2015 | - | $2.17 B(-7.2%) |
| Dec 2014 | $2.33 B(+0.7%) | $2.33 B(-3.0%) |
| Sept 2014 | - | $2.41 B(+13.6%) |
| June 2014 | - | $2.12 B(-3.6%) |
| Mar 2014 | - | $2.20 B(-5.3%) |
| Dec 2013 | $2.32 B(-16.0%) | $2.32 B(-10.2%) |
| Sept 2013 | - | $2.58 B(-0.1%) |
| June 2013 | - | $2.58 B(+8.0%) |
| Mar 2013 | - | $2.39 B(-13.3%) |
| Dec 2012 | $2.76 B(+25.2%) | $2.76 B(+1.5%) |
| Sept 2012 | - | $2.72 B(+4.4%) |
| June 2012 | - | $2.60 B(+11.0%) |
| Mar 2012 | - | $2.35 B(+6.4%) |
| Dec 2011 | $2.20 B(+27.8%) | $2.20 B(+5.4%) |
| Sept 2011 | - | $2.09 B(+18.7%) |
| June 2011 | - | $1.76 B(+14.6%) |
| Mar 2011 | - | $1.54 B(-10.8%) |
| Dec 2010 | $1.73 B(-11.8%) | $1.73 B(-8.6%) |
| Sept 2010 | - | $1.89 B(+14.2%) |
| June 2010 | - | $1.65 B(-6.6%) |
| Mar 2010 | - | $1.77 B(-9.5%) |
| Dec 2009 | $1.96 B(+99.4%) | $1.96 B(+24.3%) |
| Sept 2009 | - | $1.57 B(+9.3%) |
| June 2009 | - | $1.44 B(-8.0%) |
| Mar 2009 | - | $1.57 B(+59.7%) |
| Dec 2008 | $980.48 M(+63.0%) | $980.48 M(-8.2%) |
| Sept 2008 | - | $1.07 B(+10.0%) |
| June 2008 | - | $970.80 M(+9.1%) |
| Mar 2008 | - | $889.50 M(+47.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $601.48 M(-34.7%) | $601.48 M(-8.2%) |
| Sept 2007 | - | $655.15 M(-13.9%) |
| June 2007 | - | $761.07 M(-8.9%) |
| Mar 2007 | - | $835.10 M(-9.4%) |
| Dec 2006 | $921.58 M(+67.9%) | $921.58 M(+2.2%) |
| Sept 2006 | - | $902.11 M(+44.2%) |
| June 2006 | - | $625.48 M(+19.2%) |
| Mar 2006 | - | $524.66 M(-4.4%) |
| Dec 2005 | $549.00 M(+0.6%) | $549.00 M(-0.3%) |
| Sept 2005 | - | $550.58 M(-7.8%) |
| June 2005 | - | $596.90 M(+23.3%) |
| Mar 2005 | - | $484.23 M(-11.2%) |
| Dec 2004 | $545.45 M(-24.7%) | $545.45 M(-5.0%) |
| Sept 2004 | - | $574.36 M(-8.0%) |
| June 2004 | - | $624.05 M(-6.7%) |
| Mar 2004 | - | $669.19 M(-7.6%) |
| Dec 2003 | $724.41 M(-11.2%) | $724.41 M(-2.5%) |
| Sept 2003 | - | $742.68 M(-5.7%) |
| June 2003 | - | $787.46 M(-6.3%) |
| Mar 2003 | - | $840.31 M(+3.0%) |
| Dec 2002 | $815.72 M(-11.8%) | $815.72 M(-1.8%) |
| Sept 2002 | - | $831.07 M(-3.4%) |
| June 2002 | - | $860.47 M(-1.7%) |
| Mar 2002 | - | $875.51 M(-5.4%) |
| Dec 2001 | $925.13 M(-1.7%) | $925.13 M(+0.3%) |
| Sept 2001 | - | $922.37 M(+20.3%) |
| June 2001 | - | $766.83 M(-0.4%) |
| Mar 2001 | - | $769.54 M(-18.2%) |
| Dec 2000 | $941.14 M(+304.9%) | $941.14 M(+21.5%) |
| Sept 2000 | - | $774.56 M(+80.8%) |
| June 2000 | - | $428.32 M(+7.9%) |
| Mar 2000 | - | $396.93 M(+70.8%) |
| Dec 1999 | $232.44 M(-12.7%) | $232.44 M(+3.4%) |
| Sept 1999 | - | $224.80 M(-5.8%) |
| June 1999 | - | $238.60 M(-4.4%) |
| Mar 1999 | - | $249.70 M(-6.2%) |
| Dec 1998 | $266.30 M(-9.9%) | $266.30 M(-4.2%) |
| Sept 1998 | - | $277.90 M(+1.1%) |
| June 1998 | - | $274.90 M(-3.0%) |
| Mar 1998 | - | $283.30 M(-4.2%) |
| Dec 1997 | $295.60 M(+106.0%) | $295.60 M(-1.0%) |
| Sept 1997 | - | $298.70 M(-0.7%) |
| June 1997 | - | $300.70 M(+3.8%) |
| Mar 1997 | - | $289.60 M(+101.8%) |
| Dec 1996 | $143.50 M(+44.9%) | $143.50 M(0.0%) |
| Sept 1996 | - | $143.50 M(+94.7%) |
| June 1996 | - | $73.70 M(-18.4%) |
| Mar 1996 | - | $90.30 M(-8.8%) |
| Dec 1995 | $99.00 M(-14.8%) | $99.00 M(+0.7%) |
| Sept 1995 | - | $98.30 M(-7.4%) |
| June 1995 | - | $106.10 M(-5.1%) |
| Mar 1995 | - | $111.80 M(-3.8%) |
| Dec 1994 | $116.20 M(+90.5%) | $116.20 M(+8.9%) |
| Sept 1994 | - | $106.70 M(-3.4%) |
| June 1994 | - | $110.40 M(-3.1%) |
| Mar 1994 | - | $113.90 M(+86.7%) |
| Dec 1993 | $61.00 M(+19.6%) | $61.00 M(+20.1%) |
| Sept 1993 | - | $50.80 M(-1.6%) |
| June 1993 | - | $51.60 M(+6.0%) |
| Mar 1993 | - | $48.70 M(-4.5%) |
| Dec 1992 | $51.00 M(-10.7%) | $51.00 M(-3.6%) |
| Sept 1992 | - | $52.90 M(-2.9%) |
| June 1992 | - | $54.50 M(-1.8%) |
| Mar 1992 | - | $55.50 M(-2.8%) |
| Dec 1991 | $57.10 M(+520.7%) | $57.10 M(+76.2%) |
| Sept 1991 | - | $32.40 M(+343.8%) |
| June 1991 | - | $7.30 M(-20.7%) |
| Dec 1990 | $9.20 M | $9.20 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total assets?
- What is the all time high annual total assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual total assets year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total assets?
- What is the all time high quarterly total assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly total assets year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total assets?
The current annual total assets of VRTX is $22.73 B
What is the all time high annual total assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total assets is $22.73 B
What is Vertex Pharmaceuticals Incorporated annual total assets year-on-year change?
Over the past year, VRTX annual total assets has changed by +$4.58 B (+25.23%)
What is Vertex Pharmaceuticals Incorporated quarterly total assets?
The current quarterly total assets of VRTX is $22.24 B
What is the all time high quarterly total assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total assets is $23.92 B
What is Vertex Pharmaceuticals Incorporated quarterly total assets year-on-year change?
Over the past year, VRTX quarterly total assets has changed by +$514.00 M (+2.37%)